Matinas BioPharma Holdings, Inc. held its Annual Meeting of Stockholders on November 1, 2023, where stockholders voted on various proposals including the election of directors, approval of executive compensation, ratification of the appointment of an accounting firm, and an amendment to the Certificate of Incorporation for a reverse stock split and reduction in authorized shares.